Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
13F holders, Q2 2026
Institutional positions in Aspire Biopharma Holdings, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −2 vs. Q1 2026
- Shares held
- 6.58M
- −104.7K (−1.6%) vs. Q1 2026
- Total value
- $145.4K
- +$23.7K (+19.5%) vs. Q1 2026
- New holders
- 1
- 1 more added
- Sold out
- 3
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBPW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $145.4K |
| Q1 2026 | 31 | $121.7K |
| Q4 2025 | 31 | $142.5K |
| Q3 2025 | 31 | $246.3K |
| Q2 2025 | 31 | $395.1K |
| Q1 2025 | 29 | $639.8K |
| Q4 2024 | 28 | $378.3K |
| Q3 2024 | 32 | $343.1K |
| Q2 2024 | 35 | $289.3K |
| Q1 2024 | 36 | $299.9K |
| Q4 2023 | 37 | $590.3K |
| Q3 2023 | 40 | $494.7K |
| Q2 2023 | 41 | $490.5K |
| Q1 2023 | 36 | $399.0K |
| Q4 2022 | 37 | $627.8K |
| Q3 2022 | 37 | $1.28M |
| Q2 2022 | 37 | $1.38M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flow Traders U.S. LLC | 15,450 | $0 | 0.00% | +400+2.7% | Added |
| Investors Research Corp | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 50 | $1 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 291 | $6 | 0.00% | −8,459−96.7% | Reduced |
| Beacon Pointe Advisors, LLC | 20,000 | $400 | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 25,000 | $513 | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 41,269 | $825 | 0.00% | +41,269 | New |
| Crossingbridge Advisors, LLC | 49,846 | $997 | 0.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 50,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 25,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 50,000 | $1.02K | 0.00% | 00.0% | Unchanged |
| Limestone Investment Advisors LP | 75,000 | $1.50K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $2.14K | 0.00% | – | – |
| JPMorgan Chase & Co | – | $2.26K | 0.00% | – | – |
| Whitebox Advisors LLC | 118,750 | $2.38K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 124,924 | $2.50K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 125,000 | $2.50K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 138,536 | $3.23K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 175,000 | $3.50K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 191,021 | $3.92K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 197,144 | $3.94K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 199,999 | $4.10K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 330,664 | $6.61K | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 500,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 516,245 | $10.3K | 0.00% | −1000.0% | Reduced |
| Aristeia Capital LLC | 681,516 | $15.9K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 899,999 | $21.0K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 983,603 | $22.9K | 0.00% | 00.0% | Unchanged |
| VR Advisory Services Ltd | 0 | $0 | 0.00% | −99,692−100.0% | Sold out |
| Athos Capital Ltd | 0 | $0 | 0.00% | −21,383−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,781−100.0% | Sold out |